Both colestilan and sevelamer produced significant reductions from baseline in serum phosphorus levels ( P < @ ) , maintained for @ year , and the proportion of patients achieving target levels of @ mmol/L ( @ mg/dL ) or @ mmol/L ( @ mg/dL ) at study end were similar ( @ and @ % , respectively , for colestilan , and @ and @ % , respectively , for sevelamer ) .